Lobe Sciences Ltd. (LOBEF)
OTCMKTS · Delayed Price · Currency is USD
0.0362
0.00 (0.00%)
Feb 12, 2026, 3:35 PM EST
Lobe Sciences Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
9.95M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Aug 31, 2025 | - | - | - |
| Aug 31, 2024 | 136.21K | -704.33K | -83.80% |
| Aug 31, 2023 | 840.53K | - | - |
| Aug 31, 2022 | - | - | - |
| Aug 31, 2021 | - | - | - |
| Aug 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionLobe Sciences News
- 9 days ago - Lobe Sciences Reports First Quarter 2026 Results and Highlights - Accesswire
- 4 weeks ago - Lobe Sciences Advances Governance and Capital Markets Expertise with Appointment of Mr. Nick Karakochuk to the Board of Directors - Accesswire
- 5 weeks ago - Lobe Sciences Reports FY2025 with a Stronger Balance Sheet and Sharpened Strategy - Accesswire
- 5 weeks ago - Lobe Sciences Reports Fiscal 2025 Results and Highlights Strategic Transformation Following Leadership Transition - Accesswire
- 4 months ago - Lobe Sciences Completes Debt Settlement to Improve Balance Sheet - Accesswire
- 4 months ago - Lobe Sciences Improves Balance Sheet - Accesswire
- 5 months ago - Lobe Sciences Ltd. to Attend the ArcStone-Kingswood Growth Summit 2025 in Toronto - Newsfile Corp
- 5 months ago - Lobe Sciences Ltd. and Cynaptec Pharmaceuticals, Inc. to Present a New Therapeutic Approach for the Treatment of Chronic Cluster Headaches at Clusterbusters 2025 - Accesswire